clofibrate has been researched along with angiotensin ii in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Fairhurst, AS; Kent, G; Purdy, RE | 1 |
Newaz, M; Oyekan, A; Yousefipour, Z | 1 |
Banks, T; Oyekan, A | 1 |
Cervantes-Pérez, LG; Del Valle, L; Ibarra-Lara, L; Martínez-Lazcano, JC; Pastelín-Hernández, GS; Pérez-Severiano, F; Rubio-Ruíz, E; Sánchez-Aguilar, M; Sánchez-Mendoza, A; Soria-Castro, E | 1 |
Cervantes-Pérez, LG; Del Valle-Mondragón, L; Ibarra-Lara, L; Oidor-Chan, VH; Pastelín-Hernández, GS; Pérez-Severiano, F; Ramírez-Ortega, M; Sánchez-Aguilar, M; Sánchez-Mendoza, A; Soria-Castro, E; Torres-Narváez, JC; Zarco-Olvera, G | 1 |
Cervantes-Pérez, LG; Del Valle-Mondragón, L; Ibarra-Lara, L; Pastelín-Hernández, G; Sánchez-Aguilar, M; Sánchez-Mendoza, A; Soria-Castro, E | 1 |
7 other study(ies) available for clofibrate and angiotensin ii
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Clofibrate and vascular smooth muscle: actions on rabbit aorta preparations.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Calcium; Clofibrate; Histamine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium; Rabbits | 1981 |
Role of PPAR-gamma on the pathogenesis and vascular changes in glycerol-induced acute renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Kidney Injury; Angiotensin II; Animals; Ascorbic Acid; Clofibrate; Down-Regulation; Free Radicals; Glycerol; Kidney; Male; Nitric Oxide; Nitriles; PPAR gamma; Rats; Rats, Sprague-Dawley; Renal Circulation; Thiazolidinediones; Thromboxane A2; Vasoconstriction | 2006 |
Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
Topics: Angiotensin II; Animals; Cardiovascular Agents; Clofibrate; Fenofibrate; Hemodynamics; Male; Models, Animal; Nitric Oxide; PPAR alpha; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2008 |
PPARalpha stimulation exerts a blood pressure lowering effect through different mechanisms in a time-dependent manner.
Topics: Angiotensin II; Animals; Antioxidants; Aortic Coarctation; Blood Pressure; Clofibrate; Gene Expression Regulation; Hypertension; Lipid Peroxidation; Male; Nitric Oxide Synthase Type III; Oxidoreductases; PPAR alpha; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Angiotensin; Superoxide Dismutase; Time Factors | 2010 |
Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Aortic Coarctation; Captopril; Catalase; Clofibrate; Drug Synergism; Heart Ventricles; Hypertension; Lipid Peroxidation; Male; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; PPAR alpha; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Superoxide Dismutase; Vasodilation | 2016 |
Clofibrate improves myocardial ischemia-induced damage through regulation of renin-angiotensin system and favours a pro-vasodilator profile in left ventricle.
Topics: Angiotensin II; Animals; Clofibrate; Fibrosis; Heart Ventricles; Male; Myocardial Ischemia; Myocardium; Nitric Oxide; Oxidative Stress; Peptidyl-Dipeptidase A; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Time Factors | 2020 |